<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and latent autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> in adults (LADA) are thought to result from immune-mediated β-cell destruction </plain></SENT>
<SENT sid="1" pm="."><plain>It remains unclear why LADA is clinically less severe compared to type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>This study aimed to compare the pro-inflammatory (interferon-γ, IFN-γ) and anti-inflammatory (interleukin-13, IL-13) T-cell responses in humans with LADA and type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: IFN-γ and IL-13 T-cell responses to a panel of 16 (auto)-antigens were tested using an enzyme linked immune-spot technique and peripheral T-cells from 35 patients with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>, 59 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, 23 LADA patients, and 42 control subjects </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: LADA and type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> patients did not display any statistically significant differences in the frequency of IFN-γ or IL-13 responses to auto-antigenic stimuli, positive control or <z:chebi fb="0" ids="52290">mitogen</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Overall very low T cell reactivity to autoantigens was detected in <z:hpo ids='HP_0000001'>all</z:hpo> groups </plain></SENT>
<SENT sid="6" pm="."><plain>IL-13 responses but not IFN-γ responses to recall antigen <z:e sem="disease" ids="C0039614" disease_type="Disease or Syndrome" abbrv="">tetanus</z:e> toxoid were higher in healthy control subjects compared to patients with type 1 or type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> or LADA (P&lt;0.05) </plain></SENT>
<SENT sid="7" pm="."><plain><z:mp ids='MP_0002055'>Diabetes</z:mp>, independent of type, was associated with weaker response to recall antigen <z:e sem="disease" ids="C0039614" disease_type="Disease or Syndrome" abbrv="">tetanus</z:e> toxoid </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: LADA patients are indistinguishable from type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> patients for cellular IFN-γ and IL-13 responses upon <z:chebi fb="0" ids="52290">mitogen</z:chebi> and recall antigen stimulation </plain></SENT>
<SENT sid="9" pm="."><plain>These results extend previous findings showing that systemic cytokine/chemokine and humoral responses in type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and LADA are similar </plain></SENT>
</text></document>